• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Before Header

  • Axis Clinicals USA

Axis Clinicals

Contract Research Organization

  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice – WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23
  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice – WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23

Medical Writing

You are here: Home / Medical Writing

Medical writing in the context of Clinical Research undoubtedly plays a crucial role in the success or failure of new compounds.

AXIS Clinicals’ medical writing domain is well equipped with professionals having strong academics besides having valuable scientific experience in various therapeutic areas; help to compile, organize, write, edit and produce a wide range of medical and scientific documentation essential to deliver the quality and timeliness required to support the product development efforts.

Our clients can safely bank on our writers at any stage in their product development lifecycle – from clinical development plan and investigator brochures to regulatory submission and licensing maintenance documents. Having in-house expertise from PK|PD to pharmaco-vigilance, we are capable to work on study reports, patient narratives, DSMB updates, labeling or other documents involving study data.

The Medical Writing services at AXIS Clinicals is proficient in:

  • Clinical development plans
  • Abstracts, manuscripts and journal articles
  • Investigator brochures and annual updates
  • Informed consent forms
  • Protocols
  • Clinical study reports
  • Clinical sections of Common Technical Documents (CTDs)
  • Clinical sections of New Drug Applications (NDAs)
  • Periodic Safety Update Reports (PSURs) and other pharmaco-vigilance documents
  • Pre-FDA meeting briefing documents
  • Response to clinical hold orders
  • Preclinical study reports, expert reports and summaries
  • Data Safety Monitoring Board (DSMB) manuals
  • Written and tabular summaries

Bio-Analytical Reporting

  • Method Validation Reports
  • Bio analytical Reports
  • ISR Reports
  • Submission-ready Documentation (Hyperlinked eCTD formatting)
  • Dispatch & Archival
  • Benefit | Risk assessment reports apart from medical and scientific literature reviews

Our unique medical writing offerings are in strict adherence with ICH guidelines and similar regulatory requirements.

Primary Sidebar

Menu

  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice – WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23

Footer

  • About Us
  • Our DNA
  • Our Core Values
  • Your Preferred Partner of Choice
  • Our Focus
  • Our Leadership
  • Accreditations
  • Global Locations
  • Services
  • BA | BE Studies
  • PK | PD and Patient Studies
  • Bio-Analytical Services
  • Phase II-IV
  • Project Management
  • PK | Biostatistics & Programming
  • Medical Writing
  • Regulatory Services
  • Quality Assurance and Compliance
  • Clinical Data Management
  • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us

Copyright © 2025 · Axis Clinicals